Capecitabine “metronomic” chemotherapy for palliative treatment of elderly patients with advanced gastric cancer after fluoropyrimidine-based chemotherapy
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Capecitabine “metronomic” chemotherapy for palliative treatment of elderly patients with advanced gastric cancer after fluoropyrimidine-based chemotherapy
Authors
Keywords
-
Journal
MEDICAL ONCOLOGY
Volume 29, Issue 1, Pages 100-106
Publisher
Springer Nature
Online
2011-01-24
DOI
10.1007/s12032-010-9791-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Megestrol acetate versus metronomic cyclophosphamide in patients having exhausted all effective therapies under standard care
- (2010) N Penel et al. BRITISH JOURNAL OF CANCER
- Study of Low-Dose Capecitabine Monotherapy for Metastatic Breast Cancer
- (2010) Tetsuya Taguchi et al. CHEMOTHERAPY
- Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma
- (2010) Chih-Hung Hsu et al. JOURNAL OF HEPATOLOGY
- Metronomic chemotherapy: new rationale for new directions
- (2010) Eddy Pasquier et al. Nature Reviews Clinical Oncology
- The Immune Response and the Therapeutic Effect of Metronomic Chemotherapy With Cyclophosphamide
- (2010) Viviana R. Rozados et al. ONCOLOGY RESEARCH
- Mitomycin C plus S-1 as second-line therapy in patients with advanced gastric cancer: a noncomparative phase II study
- (2009) Se Hoon Park et al. ANTI-CANCER DRUGS
- Continuous oral capecitabine at fixed dose in patients older than 75 years with metastatic colorectal and gastric cancer: a study of the Multidisciplinary Oncology Group on Gastrointestinal Tumors
- (2009) Roberto Petrioli et al. ANTI-CANCER DRUGS
- To widen the setting of cancer patients who could benefit from metronomic capecitabine
- (2009) Margherita Nannini et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Emerging Role of Capecitabine in Gastric Cancer
- (2009) Pasquale Comella et al. PHARMACOTHERAPY
- A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer
- (2008) J-L Lee et al. BRITISH JOURNAL OF CANCER
- Antiangiogenic and anticolorectal cancer effects of metronomic irinotecan chemotherapy alone and in combination with semaxinib
- (2008) G Bocci et al. BRITISH JOURNAL OF CANCER
- Anti-angiogenic effect of 5-Fluorouracil-based drugs against human colon cancer xenografts
- (2008) Akio Ooyama et al. CANCER LETTERS
- Combined oral cyclophosphamide and bevacizumab in heavily pre-treated ovarian cancer
- (2008) José Miguel Jurado García et al. Clinical & Translational Oncology
- Oral Fluoropyrimidines (Capecitabine or S-1) and Cisplatin as First Line Treatment in Elderly Patients with Advanced Gastric Cancer: A Retrospective Study
- (2008) Y. M. Seol et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Metronomic Cyclophosphamide and Capecitabine Combined With Bevacizumab in Advanced Breast Cancer
- (2008) Silvia Dellapasqua et al. JOURNAL OF CLINICAL ONCOLOGY
- S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
- (2008) Wasaburo Koizumi et al. LANCET ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started